New data for KSI-101 from the APEX study reinforce its clinically meaningful vision gains and rapid retinal drying in macular edema secondary to inflammation (MESI)
By daniel.h.villero@gmail.com
1250 Page Mill RoadPalo Alto, CA 94304United States of America